Acrobiosystems Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	782.44	632.94	532.8	466.58	376.71	239.78
Other Revenue	12.09	12.09	10.85	7.85	8.28	6.54
Revenue	794.52	645.02	543.65	474.43	384.99	246.32
Revenue Growth (YoY)	33.63%	18.65%	14.59%	23.23%	56.30%	138.47%
Cost of Revenue	111.78	98.24	85.14	59.01	34.27	22.96
Gross Profit	682.74	546.78	458.52	415.42	350.72	223.35
Selling, General & Admin	363	321.28	254.64	185.23	115.81	55.83
Research & Development	175.55	161.87	122.22	112.47	59.55	30.65
Other Operating Expenses	2.71	2.68	2.3	0.8	0.73	0.44
Operating Expenses	544.62	487.3	379.85	299.12	177.09	87.72
Operating Income	138.12	59.48	78.67	116.3	173.63	135.64
Interest Expense	-5.45	-3.54	-2.7	-2.95	-1.15	-
Interest & Investment Income	57.17	61.91	60.92	63.25	10.72	0.8
Currency Exchange Gain (Loss)	3.56	3.56	10.87	15.5	1.42	-2.27
Other Non Operating Income (Expenses)	2.11	-2.82	-2.78	-1.72	-1.06	-1.15
EBT Excluding Unusual Items	195.5	118.58	144.99	190.39	183.56	133.02
Gain (Loss) on Sale of Investments	0.44	-1.48	0.66	0.62	0.06	0.01
Gain (Loss) on Sale of Assets	0.3	-0.35	-	0.21	0.28	-0.01
Asset Writedown	-21.16	-0	-0.11	-0.76	-0.05	-0
Other Unusual Items	8.16	8.16	15.12	24.52	11.59	0.61
Pretax Income	183.25	124.91	160.67	214.99	195.44	133.63
Income Tax Expense	10.54	4.87	13.12	15.77	22	17.94
Earnings From Continuing Operations	172.71	120.04	147.55	199.21	173.44	115.69
Minority Interest in Earnings	0.06	3.79	6.04	4.52	0.78	0.19
Net Income	172.77	123.83	153.59	203.73	174.21	115.88
Net Income to Common	172.77	123.83	153.59	203.73	174.21	115.88
Net Income Growth	58.61%	-19.38%	-24.61%	16.95%	50.34%	943.79%
Shares Outstanding (Basic)	168	168	168	168	133	126
Shares Outstanding (Diluted)	168	168	168	168	133	126
Shares Change (YoY)	0.12%	0.02%	-0.04%	26.35%	5.55%	394.52%
EPS (Basic)	1.03	0.74	0.91	1.21	1.31	0.92
EPS (Diluted)	1.03	0.74	0.91	1.21	1.31	0.92
EPS Growth	58.42%	-19.39%	-24.58%	-7.44%	42.43%	111.07%
Free Cash Flow	15.89	-82.56	-17.49	-82.1	76.31	81.52
Free Cash Flow Per Share	0.10	-0.49	-0.10	-0.49	0.57	0.65
Dividend Per Share	0.286	0.500	0.643	0.714	0.714	-
Dividend Growth	-66.67%	-22.23%	-10.00%	-	-	-
Gross Margin	85.93%	84.77%	84.34%	87.56%	91.10%	90.68%
Operating Margin	17.38%	9.22%	14.47%	24.51%	45.10%	55.07%
Profit Margin	21.75%	19.20%	28.25%	42.94%	45.25%	47.05%
Free Cash Flow Margin	2.00%	-12.80%	-3.22%	-17.30%	19.82%	33.09%
EBITDA	172.33	88.28	100.27	131.94	182.24	141.28
EBITDA Margin	21.69%	13.69%	18.44%	27.81%	47.34%	57.36%
D&A For EBITDA	34.22	28.81	21.6	15.64	8.61	5.64
EBIT	138.12	59.48	78.67	116.3	173.63	135.64
EBIT Margin	17.38%	9.22%	14.47%	24.51%	45.10%	55.07%
Effective Tax Rate	5.75%	3.90%	8.16%	7.34%	11.26%	13.42%
Revenue as Reported	794.52	645.02	543.65	474.43	384.99	246.32
Advertising Expenses	-	53.69	52	35.84	32.85	13.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.